• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泪膜成像:主观Keeler Tearscope-Plus™与客观Oculus® Keratograph 5M及LipiView®干涉仪的比较

Imaging the Tear Film: A Comparison Between the Subjective Keeler Tearscope-Plus™ and the Objective Oculus® Keratograph 5M and LipiView® Interferometer.

作者信息

Markoulli Maria, Duong Tran Bao, Lin Margaret, Papas Eric

机构信息

a School of Optometry & Vision Science, University of New South Wales , Sydney , Australia.

出版信息

Curr Eye Res. 2018 Feb;43(2):155-162. doi: 10.1080/02713683.2017.1393092. Epub 2017 Nov 14.

DOI:10.1080/02713683.2017.1393092
PMID:29135324
Abstract

PURPOSE

To compare non-invasive break-up time (NIBUT) when measured with the Tearscope-Plus™ and the Oculus® Keratograph 5M, and to compare lipid layer thicknesses (LLT) when measured with the Tearscope-Plus™ and the LipiView®. This study also set out to establish the repeatability of these methods.

METHODS

The following measurements were taken from both eyes of 24 participants on two occasions: non-invasive keratograph break-up time using the Oculus® (NIKBUT-1 and NIKBUT-average), NIBUT using the Tearscope-Plus™, and LLT using the LipiView® (minimum, maximum, and average) and Tearscope-Plus™. The Tearscope-Plus™ grades were converted to nanometers.

RESULTS

There were no significant differences between eyes (Tearscope-Plus™ NIBUT: p = 0.52; NIKBUT-1: p = 0.052; NIKBUT-average: p = 0.73; Tearscope-Plus™ LLT: p = 0.13; LipiView® average, maximum, or minimum: p = 0.68, 0.39 and 0.50, respectively) or days (Tearscope-Plus™ NIBUT: p = 0.32; NIKBUT-1: p = 0.65; NIKBUT-average: p = 0.54; Tearscope-Plus™ LLT: p = 0.26; LipiView® average, maximum, or minimum: p = 0.20, 0.09, and 0.10, respectively). LLT was significantly greater with the Tearscope-Plus™ (80.4 ± 34.0 nm) compared with the LipiView® average (56.3 ± 16.1 nm, p = 0.007), minimum (50.1 ± 15.8 nm, p < 0.001) but not maximum (67.2 ± 19.6 nm, p = 0.55). NIBUT was significantly greater with the Tearscope-Plus™ (15.9 ± 10.7 seconds) compared to the NIKBUT-1 (8.2 ± 3.5 seconds, p = 0.006) but not NIKBUT-average (10.9 ± 3.9 seconds, p = 0.08).

CONCLUSIONS

The Tearscope-Plus™ is not interchangeable with either the Oculus® K5M measurement of tear stability (NIKBUT-1) or the LipiView® maximum and minimum lipid thickness.

摘要

目的

比较使用Tearscope-Plus™和Oculus® Keratograph 5M测量的非侵入性泪膜破裂时间(NIBUT),以及使用Tearscope-Plus™和LipiView®测量的脂质层厚度(LLT)。本研究还旨在确定这些方法的可重复性。

方法

对24名参与者的双眼进行两次以下测量:使用Oculus®测量的非侵入性角膜地形图破裂时间(NIKBUT-1和NIKBUT平均值)、使用Tearscope-Plus™测量的NIBUT,以及使用LipiView®(最小值、最大值和平均值)和Tearscope-Plus™测量的LLT。将Tearscope-Plus™的等级转换为纳米。

结果

双眼之间(Tearscope-Plus™ NIBUT:p = 0.52;NIKBUT-1:p = 0.052;NIKBUT平均值:p = 0.73;Tearscope-Plus™ LLT:p = 0.13;LipiView®平均值、最大值或最小值:分别为p = 0.68、0.39和0.50)或不同天数之间(Tearscope-Plus™ NIBUT:p = 0.32;NIKBUT-1:p = 0.65;NIKBUT平均值:p = 0.54;Tearscope-Plus™ LLT:p = 0.26;LipiView®平均值、最大值或最小值:分别为p = 0.20、0.09和0.10)均无显著差异。与LipiView®平均值(56.3±16.1纳米,p = 0.007)、最小值(50.1±15.8纳米,p < 0.001)相比,Tearscope-Plus™测量的LLT显著更大,但与最大值(67.2±19.6纳米,p = 0.55)相比无显著差异。与NIKBUT-1(8.2±3.5秒,p = 0.006)相比,Tearscope-Plus™测量的NIBUT显著更长,但与NIKBUT平均值(10.9±3.9秒,p = 0.08)相比无显著差异。

结论

Tearscope-Plus™与Oculus® K5M测量的泪膜稳定性(NIKBUT-1)或LipiView®的脂质层最大和最小厚度均不可互换。

相似文献

1
Imaging the Tear Film: A Comparison Between the Subjective Keeler Tearscope-Plus™ and the Objective Oculus® Keratograph 5M and LipiView® Interferometer.泪膜成像:主观Keeler Tearscope-Plus™与客观Oculus® Keratograph 5M及LipiView®干涉仪的比较
Curr Eye Res. 2018 Feb;43(2):155-162. doi: 10.1080/02713683.2017.1393092. Epub 2017 Nov 14.
2
The repeatability of subjective and objective tear ferning assessment and its association with lipid layer thickness, non-invasive tear break-up time and comfort.主观和客观泪膜断裂评估的重复性及其与脂质层厚度、非侵入性泪膜破裂时间和舒适度的关系。
Cont Lens Anterior Eye. 2019 Aug;42(4):420-427. doi: 10.1016/j.clae.2019.04.003. Epub 2019 Apr 24.
3
Evaluation of tear film function by Oculus Keratograph 5M and IDRA ocular surface analyser.应用 Oculus Keratograph 5M 和 IDRA 眼表分析仪评估泪膜功能。
Int Ophthalmol. 2024 Oct 4;44(1):403. doi: 10.1007/s10792-024-03262-y.
4
Repeatability of Non-invasive Keratograph Break-Up Time measurements obtained using Oculus Keratograph 5M.使用 Oculus Keratograph 5M 进行非侵入性角膜破裂时间测量的可重复性。
Int Ophthalmol. 2021 Jul;41(7):2473-2483. doi: 10.1007/s10792-021-01802-4. Epub 2021 Mar 16.
5
The Effect of Optive and Optive Advanced Artificial Tears on the Healthy Tear Film.奥普特夫及奥普特夫高级人工泪液对健康泪膜的影响。
Curr Eye Res. 2018 May;43(5):588-594. doi: 10.1080/02713683.2018.1433860. Epub 2018 Feb 1.
6
Repeatability, reproducibility and agreement between three different diagnostic imaging platforms for tear film evaluation of normal and dry eye disease.三种不同诊断成像平台评估正常和干眼疾病泪膜的重复性、可再现性和一致性。
Eye (Lond). 2023 Jul;37(10):2042-2047. doi: 10.1038/s41433-022-02281-2. Epub 2022 Oct 19.
7
Intra-observer and inter-observer repeatability of ocular surface interferometer in measuring lipid layer thickness.眼表面干涉仪测量脂质层厚度的观察者内和观察者间可重复性。
BMC Ophthalmol. 2015 May 15;15:53. doi: 10.1186/s12886-015-0036-9.
8
Repeatability of Noninvasive Break-Up Time Measurements using Keratograph Oculus 3.使用角膜地形图仪 3 进行非侵入性破裂时间测量的重复性。
Cesk Slov Oftalmol. 2024;80(5):266-270. doi: 10.31348/2024/26.
9
Characteristics of the Ocular Surface in Myopic Child Candidates of Orthokeratology Lens Wear.角膜塑形镜佩戴近视儿童候选者的眼表特征
Ophthalmol Ther. 2023 Dec;12(6):3067-3079. doi: 10.1007/s40123-023-00793-y. Epub 2023 Sep 4.
10
Agreement and repeatability of four different devices to measure non-invasive tear breakup time (NIBUT).四种不同设备测量非侵入性泪膜破裂时间(NIBUT)的一致性和可重复性。
Cont Lens Anterior Eye. 2020 Oct;43(5):507-511. doi: 10.1016/j.clae.2020.02.018. Epub 2020 Mar 3.

引用本文的文献

1
Comparison of non-invasive and fluorescein tear film break-up time in a 65-year-old Norwegian population: a cross-sectional study.65岁挪威人群中非侵入性与荧光素泪膜破裂时间的比较:一项横断面研究。
BMJ Open. 2025 Apr 10;15(4):e090305. doi: 10.1136/bmjopen-2024-090305.
2
Repeatability of lipid layer thickness using LipiView® following removal of contact lenses and its relationship to comfort.使用LipiView®测量摘除隐形眼镜后脂质层厚度的可重复性及其与舒适度的关系。
Ophthalmic Physiol Opt. 2025 Mar;45(2):383-390. doi: 10.1111/opo.13445. Epub 2025 Jan 18.
3
Temporal Progression of Entry Factors into the Vicious Circle of Dry Eye in Untreated Sufferers.
未经治疗的干眼症患者进入干眼恶性循环的诱发因素的时间进展
Life (Basel). 2024 Jun 26;14(7):806. doi: 10.3390/life14070806.
4
Immune-Mediated Ocular Surface Disease in Diabetes Mellitus-Clinical Perspectives and Treatment: A Narrative Review.糖尿病中的免疫介导性眼表疾病——临床观点与治疗:一项叙述性综述
Biomedicines. 2024 Jun 12;12(6):1303. doi: 10.3390/biomedicines12061303.
5
Enhancing Meibography Image Analysis Through Artificial Intelligence-Driven Quantification and Standardization for Dry Eye Research.通过人工智能驱动的量化和标准化增强干眼病研究的眼表图像分析。
Transl Vis Sci Technol. 2024 Jun 3;13(6):16. doi: 10.1167/tvst.13.6.16.
6
Agreement between invasive and noninvasive measurement of tear film breakup time.泪膜破裂时间的侵袭性与非侵袭性测量之间的一致性。
Sci Rep. 2024 Feb 15;14(1):3852. doi: 10.1038/s41598-024-54219-1.
7
Comparing automated and manual assessments of tear break-up time using different non-invasive devices and a fluorescein procedure.比较使用不同非侵入性设备和荧光素程序的泪膜破裂时间的自动和手动评估。
Sci Rep. 2024 Jan 30;14(1):2516. doi: 10.1038/s41598-024-52686-0.
8
Promising High-Tech Devices in Dry Eye Disease Diagnosis.干眼症诊断中前景广阔的高科技设备
Life (Basel). 2023 Jun 21;13(7):1425. doi: 10.3390/life13071425.
9
Effect of a single warm compress prior to ophthalmic surgery on ocular surface and intraoperative visibility: a randomised controlled study.术前单次热敷对眼表和术中可见度的影响:一项随机对照研究。
BMJ Open Ophthalmol. 2023 Jul;8(1). doi: 10.1136/bmjophth-2023-001307. Epub 2023 Jul 4.
10
Evaluating Viscosity and Tear Breakup Time of Contemporary Commercial Ocular Lubricants on an In Vitro Eye Model.评估体外眼模型中当代商业眼用润滑剂的黏度和泪膜破裂时间。
Transl Vis Sci Technol. 2023 Jun 1;12(6):29. doi: 10.1167/tvst.12.6.29.